All women should be considered at risk for breast cancer, because about 75% of the cases occur in women who are not considered high risk, or in whom no cause is identified.
with Respect to Lifestyles, Life Events, and Breast Cancer Risks by Jayne I. Fernsler. DSN, RN C ounseling employees with respect to breast cancer risk factors is a challenging task for occupational health nurses. Breast cancer is not considered a preventable disease (Yarbro, 1985) , and some of the identified risk factors are equivocal. Several of the highest known risk factors such as family history and age at menarche cannot be controlled by women themselves.
In addition, all women should be considered at risk for breast cancer, because about 75% of the cases occur in women who are not considered high risk, or in whom no cause is identified (Seidman, Stellman, & Mushinski, 1982) . Given this situation, occupational health nurses should be prepared to provide accurate information and appropriate guidance to all women in the workplace, regardless of their known risk status.
The nature and quality of the guidance will be determined by the knowledge base of the nurse with regard to breast cancer development and risk factors. This knowledge combined with a broad perspective of breast cancer will enhance occupational health nurses' self-confidence as well as their ability to teach and counsel employees in the workplace.
This article will discuss epidemiology and risk factors of breast cancer; explain a theory of cancer development; briefly describe the risk of breast cancer development throughout the life span; and present recommendations for counseling employees in regard to breast cancer risks.
BREAST CANCER: THE BROAD PERSPECTIVE Epidemiological data have added significantly to the general body of knowledge about breast cancer. Many of the risk factors that nurses teach clients were identified through studies of the incidence and distribution of breast cancer in different populations. Current data indicate that " 8 s: . _""'-'-"both incidence and distribution patterns of breast cancer are changing in the United States and worldwide.
The general public has been exposed to some of this information through the media and the efforts of the American Cancer Society and the National Cancer Institute. Nurses, therefore, must be prepared to respond appropriately to peoples'
TABLE 1 Breast Cancer Risk Factors
Documented hereditary cancer syndrome Family history of breast cancer in first-degree relatives Nulliparity or first childbirth after age 30 Early menarche and late menopause Proliferative breast lesion (especially with atypical cells) High-dose radiation exposure to the chest area Hormone replacement therapy (in women at increased risk)* High fat diet Obesity (especially postmenopause) questions and/or misconceptions about breast cancer risks and trends.
The incidence of breast cancer varies considerably among women of different cultures, ethnic groups, and geographic locations. Traditionally, high rates have been reported for white women in Europe and North America, and for jewish women of European descent; low rates have been reported in japanese women living in japan, and in japanese and Mexican-Americans residing in the United States. Disparities in cancer incidence lessen, however, as migrant populations become acculturated into the host country. For example, the incidence of breast cancer among japanese migrants to California has gradually increased and is nearly equal to that of white American women (Miller, 1987) . This phenomenon is suggestive of the role of environment and lifestyle, especially diet, in the development of breast cancer.
Increases in the rate of breast cancer incidence also vary among populations. Although the worldwide incidence of breast cancer is increasing at an average rate of 2% annually, the increase is more pronounced in Asia, Central Europe, and South America (Miller, 1987; 1986) . In the United States, the greatest increase in incidence appears to be among Hispanics in El Paso and among black women in general (Miller, 1987) .
A great increase has also been reported in young women in the State of Washington, where the increase was greater in low income, urban residents, and in black women (White, 1987) . While the incidence of breast cancer in older women declined in Washington (White, 1987) , the mortality rate from postmenopausal breast cancer increased considerably among a traditionally low-risk Mexican-American population in Laredo, Texas, in comparison to the total population in the United States (Buchanan, 1985) . Clearly, no population is free of risk related to either incidence or mortality.
Epidemiological data have limited direct implications for counseling women in the workplace about breast cancer risk factors. Counseling interventions with regard to culture, ethnicitv, and geographic location are neither indicated, appropriate, nor feasible. Nevertheless, the data clearly show that the incidence of breast cancer is increasing and that culture and geography are not necessarily protective factors for selected groups of women.
RISK FACTORS
A simple listing of risk factors, as appears in Table 1 , does not convey the complex interaction of genetic, constitutional, reproductive, environmental, and lifestyle factors that constitute risk status. Risk is a function of unalterable genetic and constitutional factors that are modified by lifestyle, life events, and environmental factors.
Factors Related to Heredity and Life Events
Individual risk of developing breast cancer is strongly influenced by family history and heredity, childbearing activity, and duration of menstruation. Having a personal or family history of breast cancer increases the risk of developing the disease. The degree of risk depends upon the generational pattern and/or the gene pattern, the age at which affected relations were diagnosed (premenopausal or postmenopausal), and laterality of the disease (unilateral or bilateral).
In a family with one generation of women with breast cancer, if the affected woman has premenopausal bilateral breast cancer, the lifetime risk to a sister or daughter of the woman is 50%. When the affected woman has postmenopausal unilateral disease, the risk to a sister or daughter is 7%. In a family with two generations of women who have breast cancer, the same high risk (50%) exists for a sister or daughter of a woman with premenopausal bilateral disease. The risk decreases to 16% when the affected women have postmenopausal unilateral disease (Gant, 1988) .
In true hereditary as compared to familial breast cancer, a specific genetic pattern is documented in several generations. This genetic composition predisposes one to cancer development through responses to carcinogens in the environment. Hereditary syndromes such as Cowden disease, Muir syndrome, and Li-Fraumeni syndrome are associated with an increased risk of other malignancies as well as breast cancer.
Some families appear to have an association between breast cancer and other cancers such as ovarian, gastrointestinal, and malignant melanoma (Williams, 1987) . True hereditary breast cancer and other hereditary cancer syndromes are relatively rare and should not be confused with sporadic cancer occurrences within a family.
A woman's age at the time of first childbirth is a significant risk factor, with a young age (less than 30 years) decreasing risk, and an older age increasing risk of breast cancer. Nulliparity increases a woman's risk but multiparity is not universally associated with a decreased risk (Mac-Mahon, 1973; Miller, 1987; Miller, 1986; Seidman, 1982) . In some instances, high parity may be a function of a woman's having begun childbearing at a young age (Seidman, 1982) . Parity also may be inversely related to a circulating hormone, prolactin, which has been weakly associated with increased risk (DeWaard, 1988) .
The duration of menstruation, as determined by the d iffe re n ce between one's age at menarche and age at menopause, correlates positively with the degree of risk for breast cancer (Whitehead, 1985) . Presumably, a complex interplay of factors including diet, exercise, body mass, and hormones influence one's age at both menarche and menopause. The general decline in age at which women begin menstruation, along with the widespread use of oral contraceptives and abortion before first childbirth, has been offered as a potential explanation for the increasing incidence of breast cancer (Miller, 1980; White, 1987) .
Factors Related to Lifestyle
Diet may be the most significant modifiable risk factor for breast cancer. Diet is thought to account for differences in breast cancer rates among countries and ethnic and religious groups within a specific country. Diet mediates other risk factors such as body mass, which influences age at menarche, age at menopause, hormonal status, and menstrual function (Rohan, 1987; Wynder, 1984) .
A large body mass is associated with early menarche and late menopause (Miller, 1986; Rohan, 1987; Wynder, 1984) . Moreover, obesity, a function of diet, is considered a significant risk factor in postmenopausal women. Wynder (1987) has suggested that the nature and amount of dietary fat may be more influential than obesity in the development of cancer in general.
Researchers have focused on the identification of specific components of a high risk diet. While some researchers agree that high fat intake is the major dietary risk factor (Miller, 1987; Miller, 1980; Rohan, 1987; Wynder, 1987; Wynder, 1984) , others point out that animal protein and alcohol consumption also have been associated with increased risk for breast cancer (DeWaard, 1988; Rohan, 1987) . More research on dietary factors is needed as it is difficult to draw conclusions from epidemiological studies and experimental animal studies.
Research is needed to determine the mechanism by which fat increases the risk of breast cancer, specific type and amount of dietary fat that promotes carcinogenesis, and the significance of fat versus total caloric intake (Rohan, 1987; Wynder, 1987) . Miller (1986) points out that the impact of low fat dietary intervention on breast cancer incidence would become apparent only after several generations. Despite the uncertainty regarding the specific role of dietary fat in the etiology of breast cancer, support is strong for the recommendation to reduce fat and excess caloric intake (American Cancer Society, 1989; Key, 1988; Miller, 1987; Miller, 1980; Miller, 1986; Wynder, 1984) .
Stress and exercise can influence food intake, body mass, hormonal status, and menstrual functioning. Moderate physical exercise during early adolescence may reduce subsequent risk of breast cancer by delaying menarche or suppressing ovulation (Key, 1988) . Stress and exercise are mediators of risk factors rather than risk factors per se.
Exogenous Hormones
A great concern surrounding the development of breast cancer is the use of exogenous hormones, namely estrogen, in oral contraceptives and as replacement therapy in postmenopausal women. Evidence has suggested that the use of oral contraceptives does not increase risk of breast cancer (Fishman, 1987) , even in women with benign breast disease and a positive family history (The Centers for Disease Control, 1983) .
Recently, however, this evidence has been reexamined along with current data from studies of premenopausal women that suggest an increased risk of breast cancer for certain subgroups of women who use oral contraceptives. Unfortunately, the wide variation in the identified subgroups-long-term users, short-term users, very young users, nulliparous women, women with one pregnancy-among the studies, precludes the development of a definitive statement about the relationship between oral contraceptives and the risk of breast cancer. Women who have or may have an increased risk of developing breast cancer are advised to weigh the benefits and risks of using oral contraceptives (National Cancer Institute, 1989) . Evidence concerning estrogen replacement therapy in the development of breast cancer is also inconclusive. Ross et al (1980) found that at total accumulated doses of more than 1,500 mg (about 1.25 mg daily for three years) use of estrogens increased the risk of breast cancer in women with intact ovaries. The risk was further increased for women who had benign breast disease. Fishman (1987) suggested that replacement therapy may increase the risk of breast cancer in women who are already at increased risk. At low-dose levels of estrogen replacement, the risk of breast cancer is unclear. The potential benefits of such therapy in reducing or preventing coronary artery disease and osteoporosis may outweigh the potential risk of developing breast cancer (Ernster, 1988; Key, 1988) .
Factors Related to Benign Breast Disease
The widespread prevalence of benign breast disease and the association of this phenomenon with the development of breast cancer l1ave caused much anxiety among American women. One of the problems is that, even with mammography and breast tissue biopsy, pathologists can- not predict accurately which lesions will become malignant (Cardiff, 1988) . Nevertheless, a number of sources have listed a history of benign breast disease and/or a benign breast biopsy as risk factors for breast cancer (DeWaard, 1988; MacMahon, 1973; Miller, 1980; Siedman, 1982; Whitehead, 1985) . Whitehead (1985) classified tissue patterns seen on mammography and studied these classifications along with other risk factors in a predictive statistical model. The tissue patterns were found to be as significant as other risk factors, including benign breast biopsy, in predicting the risk of breast cancer. Dupont (1985) classified histological findings from breast biopsies and concluded that 70% of women who have breast biopsies for benign disease, including some women with family history of breast cancer, have nonproliferative lesions that do not place them at increased risk for breast cancer. Hutter (1985) suggests that this information be used to allay the anxiety of a large group ofwomen and concentrate on those relatively few who are truly at high risk.
The Cancer Committee of the College of American Pathologists (1986) developed a consensus statement to clarify the terms used to describe benign breast tissue and categorize breast lesions according to their relative risk of evolving into breast cancer. The consensus panel deemed the term "fibrocystic disease" unac-ceptable because it does not specify the tissue or cellular changes (p. 183). Because "fibrocystic disease" is confusing to the public, the College of American Pathologists also developed a public education pamphlet for general distribution (see Figure) .
Radiation Exposure
Exposure to ionizing radiation is a well-known risk factor for cancer in general. Radiation is believed to act as an initiating agent, especially with exposure during childhood and early adolescence, increasing the risk of developing cancer in later life. The latency period is long and the risk increases with increasing radiation dosage. An increased risk of breast cancer was found in women exposed to radiation as a result of atomic bomb explosion (McGregor, 1977) , treatment for post-partum mastitis (Shore, 1977) , repeated fluoroscopic examinations of the chest (Boice, 1977) , and treatment during infancy for enlarged thymus gland (Hildreth, 1983) .
DEVELOPMENT OF CANCER
The development of cancer is not completely understood, but is believed to involve a complex interplay of factors. The latency period between initial contact with a carcinogen and the actual appearance of a malignancy supports a two-stage theory of cancer development-ini-tiation and promotion (Pi tot, 1985) . A third step, progression or metastasis, also is included in the process by some authors (Boutwell, 1985; Cardiff, 1988) .
During initiation, a physical, chemical, or biologic agent reacts with and alters the DNA of a cell. Although this alteration is irreversible, it does not in and of itself transform the cell from a benign to a malignant state. Agents that produce permanent changes in the genetic substance of a cell are known as mutagens, and the process they initiate is called mutagenesis. Mutagens or initiating agents are most effective during the time the cell is synthesizing DNA. Although the magnitude of the effect depends upon the dose of the agent, no threshold dose is known below which no effect occurs (Pitot, 1985) . Ionizing radiation, ultraviolet radiation, certain chemicals, and selected viruses all meet the criteria for classification as initiating agents.
During promotion, which may occur long after initiation, repeated exposure to a second agent causes the altered DNA to become evident or expressed (Boutwell, 1985) . The promotion stage of the process is reversible and is thereby a potentially fruitful area for cancer prevention. Initiation and promotion occur in tandem, with initiation preceding promotion.
Exposure to promoting agents,
The risk of breast cancer increases with age, as the period of exposure to carcinogens increases. alone or prior to initiation of the cell, does not cause malignant growth. Animal studies have demonstrated that certain drugs, hormones, dietary fat, alcoholic beverages, asbestos, cigarette smoke, and halogenated hydrocarbons are promoting agents (Pitot, 1985) . Considering the prevalence of these substances, potential for exposure is high throughout the life span. The properties of initiating and promoting agents are summarized in Table 2 .
The relationship between initiators and promoters, as described in the two-stage theory of cancer development, is not clear cut. For example, radiation, cigarette smoke, and certain viruses and chemicals are both initiating and promoting agents because they are mutagenic (produce permanent change in genetic material) and carcinogenic (promote malignant transformation) (Pitot, 1985) .
Although theoretically cancer could develop as a result of exposure to a single agent, in reality the combination of agents and exposure periods leading to the expression of cancer is very complex. In the case of hereditary cancer, genetically altered cells that are inherited may require exposure to only promoters for transformation to a malignant state (Oppenheimer, 1985) . Thus, the two-stage theory provides a useful, but not perfect, explanation of cancer development.
RISK OF BREAST CANCER DEVELOPMENT
THROUGHOUT LIFE Breast cancer is initiated, promoted, or mediated by a number of factors throughout the life span. In the case of hereditary breast cancer, risk begins in utero with the inheritance of genetically altered cells. At birth, or perhaps even in utero, genetic predisposition determines one's sensitivity to carcinogens in the environment. During childhood and adolescence, regardless of genetic predisposition, breast tissue is particularly sensitive to ionizing radiation (Boice, 1977; Hildreth, 1983; McGregor, 1977) .
The time around the menarche may be a vulnerable period for tumor initiation (MacMahon, 1973) from other agents in addition to radiation. Miller (1987) hypothesized that the critical period for exposure of breast tissue to carcinogens was between menarche and first completed pregnancy. The longer the period, the greater the potential exposure to initiating agents. Logically, then, all factors that contribute to an early menarche (large body mass, high fat diet, lack of exercise, increased hormone levels) or to delayed term pregnancy (birth control, particularly oral contraceptives, and possibly abortion) mediate the risk of breast cancer by increasing the period of vulnerability.
Delayed first pregnancy may act more directly by promoting malignant transformation of cells (Mac-Mahon, 1973; Miller, 1987) . Factors such as exercise and a low-fat diet, which can delay menarche (Key, 1988) , mediate the risk of breast cancer by decreasing the period of vulnerability to initiating agents. First pregnancy before the age of 30 decreases the risk by retarding malignant transformation of previously initiated breast tissue (MacMahon, 1973) .
The risk of breast cancer increases with age, as the period of exposure to carcinogens increases. A particularly vulnerable period is just before menopause, when the risk of breast cancer increases sharply. During this time, estrogen may act as an agent by increasing the number of breast cells that are available for initiation and/or bypromoting malignant transformation of cells.
When estrogen stimulation ceases or declines at menopause, although malignant transformation still occurs as initiated cells are exposed to other promoting agents, the risk of breast cancer decreases (Miller, 1980) . Presumably, most of the factors that contribute to an early menarche also foster a late menopause, which increases the period of vulnerability to estrogen stimulation. After menopause, risk status may be modified (increased) by obesity and estrogen therapy, particularly if proliferative lesions are present in the breast.
RECOMMENDATIONS FOR EMPLOYEE COUNSELING
The review of breast cancer risk factors has several implications for employee counseling. As stated previously, all women should be considered at risk for breast cancer. Personal counseling should be preceded by thorough assessment of not only risk factors but also the response of the employee to the potential threat of breast cancer. Some women may be blissfully unaware of their risks while others may worry excessively about developing breast cancer. In addition, male employees may seek counseling or information about the risk status of spouses or significant others. The teaching and counseling skills of occupational health nurses need to be honed sufficiently to accommodate all of these situations.
Knowledge about factors that influence employee behaviors regarding their risks is useful for planning strategies to encourage health promoting behaviors. One study of factors that influenced employees' participation or non-participation in a low-cost mammography screening program revealed that participants, in comparison to nonparticipants, were more knowledgeable about breast cancer, perceived that mammog- -1989 (p.10) . COjYyright1989by American Cancer Society, Inc. Adaptedwithpermission. All suspicious lumps raphy was more beneficial, and perceived themselves as significantly more susceptible to breast cancer. Employees who did not participate in mammography screening cited fear of radiation, high cost, ineffectiveness of mammography in detecting breast cancer, concern about the long-term effects of the procedure, failure of their health care provider to recommend the procedure, and preference for having the procedure done through their own health care provider. Interestingly, 25% of the nonparticipants reported having breast lumps or a family history of breast cancer (Rutledge, 1988) . These findings suggest potentially fruitful areas for employee education programs.
Note. From Cancer Facts and Figures
All employees should be taught about methods for early detection of breast cancer, including breast selfexamination, examination by a professional, and mammography. The American Cancer Society guidelines are a useful model for this information (see Table 3 ). It should be emphasized that the guidelines are for women at normal risk and that the frequency of mammography and examination may increase if high risk factors are identified.
Because some women fear the effects of radiation exposure with mammography, the occupational health nurse should explain the difference between very low-dose exposure with mammography and high-dose exposure with repeated treatments to the chest area or with a nuclear accident. The nurse should emphasize that the benefit of the procedure far outweighs the risk.
Although primary prevention of breast cancer may not be possible, sufficient knowledge of the risk factors is available to advise employees regarding dietary modifications, exercise, and weight control. The American Cancer Society has useful dietary recommendations (see Table  4 ). Although the Cancer Society sets no specific limits on fat intake, other sources suggest limiting fat intake to no more than 30% (Miller, 1986) or 25% (Wynder, 1984) of total calories.
Regardless of the specifics, overall recommendations for dietary modi-fications, exercise, and weight control are consistent with those for promoting healthy lifestyle and for preventing or reducing coronary artery disease and cancers other than breast cancer. Employees should be encouraged to implement these recommendations within their households and to foster healthy habits in their children, in light of the evidence that women may be particularly vulnerable to cancer-initiating agents around the time of menarche.
Young employees should be informed about the risk of delaying childbearing, particularly if they are already at high risk of developing breast cancer. The occupational health nurse should be sensitive to the private nature of decisions about childbearing and to other factors that influence these decisions, such as maturity, marital status, financial status, and employee maternity benefits.
Postmenopausal employees may have concerns about estrogen replacement therapy. Although it has been suggested that women avoid using estrogen at menopause (Miller, 1987) , low-dose therapy combined with low-fat diet and exercise is believed to produce an overall effect that is potentially more beneficial than harmful to a woman's health (Ernster. 1988; Key, 1988) . With such a regimen, the lowest dose possible can be used to control menopausal symptoms such as hot flashes.
Employees with a history of familial cancer and/or breast cancer should be referred to a center that has genetic counseling services and a surveillance and management program. The occupational health nurse can be helpful in supporting recommendations for risk reduction, after the nature and magnitude of the risk have been determined. Women with a family history of breast cancer frequently overestimate their risk of developing the disease (Ottman, 1983) and may even plan their lives around the eventual diagnosis (Kelly, 1987) .
Consequently, the nurse should assess the employee's understanding of her risk and the meaning of the risk to both the employee and the family. By clarifying and interpreting information and focusing on positive factors, such as advances in techniques for early detection and treatment (Kelly, 1987; Lynch, 1981) , the nurse can counter misconceptions that contribute to feelings of hopelessness and helplessness.
Perhaps the most common counseling situation with regard to breast cancer risk factors involves employees with benign breast disease. These women should be advised that mammography and breast biopsy can be performed to determine if they have
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Note. From Cancer Facts and Figures-1989 (pp. 21-22) . Copyright 1989 by American Cancer Society, Inc. Adapted with permission.
FIGURE

Is Fibrocystic Disease of the Breast Precancerous?
A public service pamphlet available from the American College of Pathologists 5202 Old Orchard Road Skokie, IL 60077 (312) 966-5700 accumulates, more definitive risk factors will be identified, and recommendations for prevention and early detection will be revised. Improved technology will provide the means for continually increasing early detection of breast cancer. Early detection may in turn influence incidence rates in populations where such technology is available to the public. Biomarkers may be developed to identify, reliably and accurately, women who will eventually develop breast cancer. Perhaps in time, specific methods will be developed to prevent and/or reverse both tumor initiation and promotion throughout the life span.
Occupational health nurses continue to playa vital role in providing information and counseling to employees in the workplace. The specific content of the nurseemployee interaction should reflect the current data about breast cancer. The future goal of education and counseling will be primary prevention as well as early detection of breast cancer.
FUTURE DIRECTIONS
As the literature on breast cancer proliferative lesions that increase their risk for breast cancer.
Women with nonproliferative lesions can be given reassurance, while those with proliferative lesions should be referred for follow-up or for intensive high-risk surveillance, depending upon the presence of atypical changes (Hutter, 1985) . The public education brochure from the College of American Pathologists, (see Figure) could be distributed as an adjunct to teaching employees about the meaning of fibrocystic disease.
Women who are contemplating prophylactic mastectomy should be assisted to get a sound assessment of their genetic, histological, and psychological status, as well as reliable information about the procedure and options for reconstruction (Osborne, 1987) . A woman's decision regarding prophylactic mastectomy should be unhurried and should be guided by knowledge rather than dictated by fear.
